Truist Securities bolsters healthcare investment banking team
Rhea-AI Summary
Truist Securities has announced three key appointments to its healthcare investment banking team, enhancing its industry expertise. Jefferson Rives, with 20 years of experience, joins as managing director and head of healthcare technology from Barclays. Max Riso, with 11 years in healthcare investment banking, becomes managing director in biotech, coming from Citi. Dheeraj Chinthalapelly, with over eight years of experience, joins as director in biotech from UBS and Credit Suisse.
These strategic hires aim to capitalize on the robust activity in Truist's healthcare practice and anticipated industry momentum. The expanded team is expected to deliver innovative solutions and actionable ideas to clients navigating the evolving healthcare landscape.
Positive
- Expansion of healthcare investment banking team with three experienced professionals
- Strengthening of expertise in healthcare technology and biotech sectors
- Robust activity reported in Truist's healthcare practice
Negative
- None.
News Market Reaction – TFC
In the trading session that priced this news, TFC gained 1.12%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
New additions expand depth and breadth of platform
- Jefferson Rives, managing director and head of healthcare technology, joins from Barclays. Rives has 20 years of experience, including leading roles within the Wells Fargo and Morgan Stanley global healthcare teams. He is a graduate of the University of
North Carolina –Chapel Hill and received his MBA from the Kellogg School of Management at Northwestern University. - Max Riso, managing director, biotech, joins from Citi's healthcare investment banking group. Riso has 11 years of healthcare investment banking experience, including roles with PJT Partners and Jefferies. He is a graduate of the University of
Florida and received his MBA from the University ofMichigan's Ross School of Business. - Dheeraj Chinthalapelly, director, biotech, joins from UBS and Credit Suisse, where he collectively spent more than eight years. He is a graduate of the India Institute of Technology and received his MBA from NYU Stern School of Business.
"Our healthcare practice has seen robust activity this year and we anticipate momentum in the industry will continue," said Pat Stevens, head of Healthcare Investment Banking Group. "The addition of
Riso and Chinthalapelly will be based in
About Truist Securities
Truist Securities is the full-service corporate and investment banking arm of Truist Financial Corporation (NYSE: TFC). With a rich history extending back more than 125 years, Truist Securities offers a robust capital markets and investment banking platform that includes a comprehensive array of strategic advisory, mergers and acquisition, and capital markets capabilities for corporate and institutional clients, including sales, trading, and research services in both fixed income and equity. The firm also provides corporate finance, asset finance, risk management, liquidity, and treasury management solutions to meet clients' full spectrum of financial needs. Headquartered in
© 2024 Truist Financial Corporation. Truist and Truist Securities are service marks of Truist Financial Corporation. All rights reserved. Truist Securities is the trade name for the corporate and investment banking services of Truist Financial Corporation and its subsidiaries. Securities and strategic advisory services are provided by Truist Securities, Inc., member FINRA and SIPC. Lending, financial risk management, and treasury management and payment services are offered by Truist Bank. Deposit products are offered by Truist Bank, Member FDIC.
View original content to download multimedia:https://www.prnewswire.com/news-releases/truist-securities-bolsters-healthcare-investment-banking-team-302222825.html
SOURCE Truist Financial Corporation